Cefotaxime

Generic Name
Cefotaxime
Brand Names
Claforan
Drug Type
Small Molecule
Chemical Formula
C16H17N5O7S2
CAS Number
63527-52-6
Unique Ingredient Identifier
N2GI8B1GK7
Background

Cefotaxime is a third-generation cephalosporin antibiotic. Like other third-generation cephalosporins, it has broad spectrum activity against Gram positive and Gram negative bacteria. In most cases, it is considered to be equivalent to ceftriaxone in terms of safety and efficacy. Cefotaxime sodium is marketed under various trade names including Claforan (San...

Indication

Used to treat gonorrhoea, meningitis, and severe infections including infections of the kidney (pyelonephritis) and urinary system. Also used before an operation to prevent infection after surgery.

Associated Conditions
Bone and Joint Infections caused by susceptible Bacterial Infections, Central Nervous System Infections caused by susceptible Bacterial Infections, Genitourinary tract infection caused by susceptible Bacterial Infections, Gynaecological infection caused by susceptible bacteria, Intraabdominal Infections caused by susceptible Bacterial Infections, Lower Respiratory Tract Infection (LRTI) caused by susceptible bacteria, Postoperative Wound Infection, Septicemia caused by susceptible Bacterial Infections, Skin and skin-structure infections caused by susceptible bacteria
Associated Therapies
-

Cerebral Antibiotics Distribution After Acute Brain Injury

First Posted Date
2010-02-01
Last Posted Date
2016-10-11
Lead Sponsor
Poitiers University Hospital
Target Recruit Count
18
Registration Number
NCT01059890
Locations
🇫🇷

Poitiers University Hospital - 2 rue de la Milétrie - Réanimation chirugicale, Poitiers, France

Effect of, OAT3, on the Renal Secretion of Cefotaxime

Phase 1
Completed
Conditions
Interventions
First Posted Date
2005-09-16
Last Posted Date
2014-10-29
Lead Sponsor
University of California, San Francisco
Target Recruit Count
24
Registration Number
NCT00187655
© Copyright 2024. All Rights Reserved by MedPath